Evidence map›Paper›PMID 42610894›Full record

ArticleAnalytical chemistry2026

High-Ratio Partial Proteolysis with Carrier Proteome (HOLSER) Enables Global Structure Profiling and Site-Resolved Elucidation of Ligand-Protein Interactions.

Xuepei Zhang, Hassan Gharibi, Bohdana Sokolova, Zhaowei Meng, Hezheng Lyu, Amir Ata Saei, Massimiliano Gaetani, Roman A Zubarev

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xuepei ZhangDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.
Hassan GharibiDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.ORCID 0000-0002-3072-4929
Bohdana SokolovaDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.ORCID 0000-0003-3751-7129
Zhaowei MengDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.ORCID 0000-0002-7721-2795
Hezheng LyuDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.
Amir Ata SaeiDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-17 177Stockholm, Sweden.
Massimiliano GaetaniDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.ORCID 0000-0001-5610-0797
Roman A ZubarevDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177Stockholm, Sweden.ORCID 0000-0001-9839-2089

Funding

Cancerfonden 22 1967 PjHorizon 2020 Framework Programme 956314Novo Nordisk Fonden NNF25OC0100921Vetenskapsr?det 2021-05223Vetenskapsr?det 2023-02692
6 · The paper itself

Abstract

Understanding how cellular proteins interact with their environment, including endogenous and exogenous molecules, is critical for elucidating mechanisms of cellular regulation and drug action. Partial proteolysis-based techniques offer peptide-level resolution of ligand-induced conformational changes but are limited by modest proteome coverage and depth, as well as sensitivity to the experimental conditions. To overcome these limitations, we developed high-ratio partial proteolysis with carrier proteome (HOLSER), an efficient workflow that features an extended digestion time for reduced peptide yield variability as well as tandem mass tag multiplexing that includes full digests for enhanced proteome depth and sequence coverage, as well as higher precision of peptide abundance measurements. We demonstrate HOLSER capabilities of probing structural changes on the scale of specific binding sites for kinase target mapping, individual protein domains for structural mapping of the FKBP-mTOR complex in response to rapamycin, as well as global proteome structure profiling.

Indexed as

ProteolysisProteomeBinding SitesHumansLigandsProtein BindingProteomicsSirolimusTandem Mass SpectrometryTOR Serine-Threonine KinasesLigandsProteomeSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID42610894
PMCPMC13492042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.